Center for iPS Cell Research and Application (CiRA)

Using a microscopic multi-organ model system to understand bronchi-vasculature interactions during SARS-CoV-2 infections

Using a microscopic multi-organ model system to understand bronchi-vasculature interactions during SARS-CoV-2 infections

Constructing a deep generative approach for functional RNA design

Constructing a deep generative approach for functional RNA design

Learning from renal development to generate better kidney organoids for regenerative medicine

Learning from renal development to generate better kidney organoids for regenerative medicine

Deciphering the crosstalk between bFGF and integrin signaling in maintaining the properties of primed hiPSCs

Deciphering the crosstalk between bFGF and integrin signaling in maintaining the properties of primed hiPSCs

Shifting energy distribution to treat a rare genetic disorder

Shifting energy distribution to treat a rare genetic disorder

Establishing a revolutionary model to study early human embryonic development

Establishing a revolutionary model to study early human embryonic development

Developing more advanced renal organoids to model polycystic kidney disease

Developing more advanced renal organoids to model polycystic kidney disease

Using Single-antibodies as a New Ingenious Tool to Build Bio-circuitry

Using Single-antibodies as a New Ingenious Tool to Build Bio-circuitry

Stretching and stimulating engineered heart tissues to accurately portray hypertrophic cardiomyopathy

Stretching and stimulating engineered heart tissues to accurately portray hypertrophic cardiomyopathy

Delineating the dynamic transcriptional and epigenetic landscape regulating hematopoiesis

Delineating the dynamic transcriptional and epigenetic landscape regulating hematopoiesis

iPSC-derived kidney organoids to model a lifelong renal disease

Capturing the lay public's opinions on genome editing of human embryos

Capturing the lay public's opinions on genome editing of human embryos

Identification of Potential Putative Drug Compounds for Treating Interstitial Lung Disease

Optimizing the Tet-On System for Homogeneous iPSC Myogenic Differentiation

Creating an iPS Cell Resource for Rare and Intractable Diseases

Creating an iPS Cell Resource for Rare and Intractable Diseases

Exploring New Avenues in DMD Treatment: CRISPR-Cas3's Multi-Exon Skipping Approach